These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6397289)

  • 41. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
    Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absolute neonatal insulin levels in children of insulin-requiring diabetic patients.
    Martin FI
    Am J Obstet Gynecol; 1976 May; 125(1):71-2. PubMed ID: 1275016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1985 Feb; 134(2):1048-52. PubMed ID: 3880786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of diabetes during pregnancy with Des-Phe insulin: preliminary results (author's transl)].
    Peters FD; Dilger J; Roemer VM
    Dtsch Med Wochenschr; 1979 Jul; 104(27):973-5. PubMed ID: 572289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
    Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [DES-PHE-insulin therapy in diabetic patients during pregnancy (preliminary report)].
    Peters FD; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):107-8. PubMed ID: 485230
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical significance of insulin antibodies in insulin-treated diabetic patients.
    Van Haeften TW
    Diabetes Care; 1989 Oct; 12(9):641-8. PubMed ID: 2676431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum.
    Ronkainen MS; Hämäläinen AM; Koskela P; Akerblom HK; Knip M;
    Clin Exp Immunol; 2001 May; 124(2):190-6. PubMed ID: 11422194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immunogenicity of new insulins.
    Deckert T
    Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Insulin antibodies in diabetic pregnancy.
    Tamás G; Békefi D; Gaál O
    Lancet; 1975 Mar; 1(7905):521. PubMed ID: 46988
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interrelations of blood levels of contrainsular hormones and titers of insulin antibodies in diabetics treated with insulin].
    Vakov L
    Vutr Boles; 1986; 25(6):70-3. PubMed ID: 3551331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 57. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
    Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The new insulins. Their characteristics and clinical indications.
    Home PD; Alberti KG
    Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatal fulminating diabetes mellitus.
    Jewett JF
    N Engl J Med; 1976 Jun; 294(23):1289-90. PubMed ID: 817201
    [No Abstract]   [Full Text] [Related]  

  • 60. Desensitization with human (recombinant DNA) insulin.
    Bodendorfer TW; Brown ME; Frankel EH; Palay BH; Fulp SR
    Drug Intell Clin Pharm; 1985 Nov; 19(11):827-9. PubMed ID: 3905321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.